The accuracy of CA125 for detecting early-stage ovarian cancer is limited; only 50% of early-stage patients have elevated CA125 levels, leading to a low sensitivity (50–62%) for detecting early-stage ovarian cancer. Here, MUC16 is linked to ovarian cancer.